These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15254443)

  • 1. Prophylaxis against opportunistic infections in persons infected with human immunodeficiency virus.
    Martin JE; Besch CL; ;
    Am J Med Sci; 2004 Jul; 328(1):64-9. PubMed ID: 15254443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.
    Mofenson LM; Brady MT; Danner SP; Dominguez KL; Hazra R; Handelsman E; Havens P; Nesheim S; Read JS; Serchuck L; Van Dyke R; ; ; ; ;
    MMWR Recomm Rep; 2009 Sep; 58(RR-11):1-166. PubMed ID: 19730409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America.
    Kaplan JE; Benson C; Holmes KK; Brooks JT; Pau A; Masur H; ; ;
    MMWR Recomm Rep; 2009 Apr; 58(RR-4):1-207; quiz CE1-4. PubMed ID: 19357635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guidelines for preventing opportunistic infections among HIV-infected persons--2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America.
    Masur H; Kaplan JE; Holmes KK; ;
    Ann Intern Med; 2002 Sep; 137(5 Pt 2):435-78. PubMed ID: 12617574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guidelines for preventing opportunistic infections among HIV-infected persons--2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America.
    Kaplan JE; Masur H; Holmes KK; ;
    MMWR Recomm Rep; 2002 Jun; 51(RR-8):1-52. PubMed ID: 12081007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preface to the 1997 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. USPHS/IDSA Prevention of Opportunistic Infections Working Group. US Public Health Service/Infectious Diseases Society of America.
    Clin Infect Dis; 1997 Oct; 25 Suppl 3():S299-312. PubMed ID: 9356831
    [No Abstract]   [Full Text] [Related]  

  • 7. 2001 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus.
    US Public Health Service, Infectious Diseases Society of America, Prevention of Opportunistic Infections Working Group
    Infect Dis Obstet Gynecol; 2002; 10(1):3-64. PubMed ID: 12090361
    [No Abstract]   [Full Text] [Related]  

  • 8. Essentials from the 2015 European AIDS Clinical Society (EACS) guidelines for the treatment of adult HIV-positive persons.
    Ryom L; Boesecke C; Gisler V; Manzardo C; Rockstroh JK; Puoti M; Furrer H; Miro JM; Gatell JM; Pozniak A; Behrens G; Battegay M; Lundgren JD;
    HIV Med; 2016 Feb; 17(2):83-8. PubMed ID: 26548563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylaxis for opportunistic infections in an era of effective antiretroviral therapy.
    Powderly WG
    Clin Infect Dis; 2000 Aug; 31(2):597-601. PubMed ID: 10987727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. U.S. Public Health Service (USPHS) and Infectious Diseases Society of America (IDSA).
    Infect Dis Obstet Gynecol; 2000; 8(1):5-74. PubMed ID: 10741830
    [No Abstract]   [Full Text] [Related]  

  • 11. Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America.
    Benson CA; Kaplan JE; Masur H; Pau A; Holmes KK; ; ;
    MMWR Recomm Rep; 2004 Dec; 53(RR-15):1-112. PubMed ID: 15841069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [2008 prevention of opportunistic infections in HIV-infected adolescents and adults guidelines. Recommendations of GESIDA/National AIDS Plan AIDS Study Group (GESIDA) and National AIDS Plan].
    ;
    Enferm Infecc Microbiol Clin; 2008; 26(7):437-64. PubMed ID: 18842240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discontinuation of primary prophylaxis against Mycobacterium avium complex infection in HIV-infected persons receiving antiretroviral therapy: observations from a large national cohort in the United States, 1992-2002.
    Brooks JT; Song R; Hanson DL; Wolfe M; Swerdlow DL;
    Clin Infect Dis; 2005 Aug; 41(4):549-53. PubMed ID: 16028167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1997 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: disease-specific recommendations. USPHS/IDSA Prevention of Opportunistic Infections Working Group. US Public Health Services/Infectious Diseases Society of America.
    Clin Infect Dis; 1997 Oct; 25 Suppl 3():S313-35. PubMed ID: 9356832
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations. Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1998 Oct; 47(RR-20):1-58. PubMed ID: 9809743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guidelines issued for prevention of opportunistic infections in persons with HIV.U.S. Public Health Service and Infectious Disease Society of America.
    Am Fam Physician; 1995 Nov; 52(6):1922, 1924-7. PubMed ID: 7484696
    [No Abstract]   [Full Text] [Related]  

  • 17. Treating opportunistic infections among HIV-exposed and infected children: recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America.
    Mofenson LM; Oleske J; Serchuck L; Van Dyke R; Wilfert C
    Clin Infect Dis; 2005 Feb; 40 Suppl 1():S1-84. PubMed ID: 15655768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance measures for guidelines on preventing opportunistic infections in patients infected with human immunodeficiency virus.
    Gross PA; Asch S; Kitahata MM; Freedberg KA; Barr D; Melnick DA; Bozzette SA
    Clin Infect Dis; 2000 Apr; 30 Suppl 1():S85-93. PubMed ID: 10770917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discontinuation of prophylaxis for HIV-associated opportunistic infections in the era of highly active antiretroviral therapy.
    Hermsen ED; Wynn HE; McNabb J
    Am J Health Syst Pharm; 2004 Feb; 61(3):245-56. PubMed ID: 14986554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: an overview. USPHS/IDSA Prevention of Opportunistic Infections Working Group.
    Kaplan JE; Masur H; Holmes KK; Wilfert CM; Sperling R; Baker SA; Trapnell CB; Freedberg KA; Cotton D; Powderly WG
    Clin Infect Dis; 1995 Aug; 21 Suppl 1():S12-31. PubMed ID: 8547500
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.